Raymond James Financial Services Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-848
| Closed | -$304K | – | 3314 |
|
|
2023
Q3 | $304K | Sell |
848
-40
| -5% | -$15.4K | ﹤0.01% | 2641 |
|
|
2023
Q2 | $337K | Sell |
888
-1,341
| -60% | -$546K | ﹤0.01% | 2586 |
|
|
2023
Q1 | $1.07M | Buy |
2,229
+1,382
| +163% | +$647K | ﹤0.01% | 1864 |
|
|
2022
Q4 | $356K | Sell |
847
-128
| -13% | -$51.7K | ﹤0.01% | 2475 |
|
|
2022
Q3 | $407K | Buy |
975
+46
| +5% | +$22.9K | ﹤0.01% | 2368 |
|
|
2022
Q2 | $460K | Buy |
929
+3
| +0.3% | +$1.56K | ﹤0.01% | 2335 |
|
|
2022
Q1 | $522K | Sell |
926
-1,503
| -62% | -$906K | ﹤0.01% | 2353 |
|
|
2021
Q4 | $1.83M | Buy |
2,429
+1,074
| +79% | +$804K | ﹤0.01% | 1600 |
|
|
2021
Q3 | $1.01M | Buy |
1,355
+81
| +6% | +$60.7K | ﹤0.01% | 1949 |
|
|
2021
Q2 | $821K | Buy |
1,274
+115
| +10% | +$70K | ﹤0.01% | 2075 |
|
|
2021
Q1 | $662K | Sell |
1,159
-993
| -46% | -$588K | ﹤0.01% | 2106 |
|
|
2020
Q4 | $1.25M | Sell |
2,152
-372
| -15% | -$212K | ﹤0.01% | 1565 |
|
|
2020
Q3 | $1.3M | Buy |
2,524
+1,736
| +220% | +$879K | ﹤0.01% | 1385 |
|
|
2020
Q2 | $356K | Buy |
788
+74
| +10% | +$32.7K | ﹤0.01% | 2137 |
|
|
2020
Q1 | $250K | Sell |
714
-854
| -54% | -$314K | ﹤0.01% | 1947 |
|
|
2019
Q4 | $580K | Sell |
1,568
-168
| -10% | -$59.2K | ﹤0.01% | 1871 |
|
|
2019
Q3 | $578K | Buy |
1,736
+344
| +25% | +$112K | ﹤0.01% | 1812 |
|
|
2019
Q2 | $435K | Buy |
1,392
+11
| +0.8% | +$3.29K | ﹤0.01% | 2011 |
|
|
2019
Q1 | $422K | Sell |
1,381
-1,392
| -50% | -$376K | ﹤0.01% | 1997 |
|
|
2018
Q4 | $644K | Sell |
2,773
-161
| -5% | -$43.2K | ﹤0.01% | 1512 |
|
|
2018
Q3 | $918K | Buy |
2,934
+75
| +3% | +$23.3K | ﹤0.01% | 1517 |
|
|
2018
Q2 | $825K | Sell |
2,859
-9
| -0.3% | -$2.48K | ﹤0.01% | 1541 |
|
|
2018
Q1 | $717K | Sell |
2,868
-3,349
| -54% | -$853K | ﹤0.01% | 1515 |
|
|
2017
Q4 | $1.48M | Buy |
6,217
+188
| +3% | +$45.6K | 0.01% | 1049 |
|
|
2017
Q3 | $1.34M | Sell |
6,029
-335
| -5% | -$75.4K | 0.01% | 1122 |
|
|
2017
Q2 | $1.44M | Buy |
6,364
+78
| +1% | +$17K | 0.01% | 1039 |
|
|
2017
Q1 | $1.25M | Buy |
+6,286
| New | +$1.21M | 0.01% | 1052 |
|
Other funds holding BIO
VAM
